TDOCTeladoc Health, Inc.

NYSE teladochealth.com


$ 8.75 $ 0.04 (0.46 %)    

Tuesday, 17-Sep-2024 08:38:47 EDT
QQQ $ 476.45 $ 0.48 (0.1 %)
DIA $ 417.33 $ 2.44 (0.59 %)
SPY $ 562.48 $ 0.83 (0.15 %)
TLT $ 101.29 $ 0.92 (0.92 %)
GLD $ 238.61 $ -0.02 (-0.01 %)
$ 8.16
$ 8.71
$ 8.67 x 300
-- x --
$ 8.71 - $ 8.75
$ 6.76 - $ 22.54
5,024,803
na
1.4B
$ 1.10
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-01-2024 06-30-2024 10-Q
2 04-26-2024 03-31-2024 10-Q
3 02-23-2024 12-31-2023 10-K
4 10-27-2023 09-30-2023 10-Q
5 07-28-2023 06-30-2023 10-Q
6 05-02-2023 03-31-2023 10-Q
7 03-01-2023 12-31-2022 10-K
8 11-02-2022 09-30-2022 10-Q
9 08-03-2022 06-30-2022 10-Q
10 05-02-2022 03-31-2022 10-Q
11 02-28-2022 12-31-2021 10-K
12 11-01-2021 09-30-2021 10-Q
13 08-02-2021 06-30-2021 10-Q
14 05-03-2021 03-31-2021 10-Q
15 03-01-2021 12-31-2020 10-K
16 11-06-2020 09-30-2020 10-Q
17 07-30-2020 06-30-2020 10-Q
18 04-29-2020 03-31-2020 10-Q
19 02-26-2020 12-31-2019 10-K
20 10-30-2019 09-30-2019 10-Q
21 07-31-2019 06-30-2019 10-Q
22 04-30-2019 03-31-2019 10-Q
23 02-27-2019 12-31-2018 10-K
24 11-01-2018 09-30-2018 10-Q
25 08-01-2018 06-30-2018 10-Q
26 05-01-2018 03-31-2018 10-Q
27 02-27-2018 12-31-2017 10-K
28 11-01-2017 09-30-2017 10-Q
29 08-02-2017 06-30-2017 10-Q
30 05-08-2017 03-31-2017 10-Q
31 03-01-2017 12-31-2016 10-K
32 10-27-2016 09-30-2016 10-Q
33 08-03-2016 06-30-2016 10-Q
34 05-10-2016 03-31-2016 10-Q
35 03-03-2016 12-31-2015 10-K
36 11-02-2015 09-30-2015 10-Q
37 08-12-2015 06-30-2015 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 jp-morgan-maintains-neutral-on-teladoc-health-lowers-price-target-to-9

JP Morgan analyst Lisa Gill maintains Teladoc Health (NYSE:TDOC) with a Neutral and lowers the price target from $16 to $9.

 why-arkk-stalled-as-qqq-took-off-harsh-lessons-over-past-5-years

ARKK's high-risk, high-reward strategy has led to a rollercoaster ride with no brakes, while QQQ's safer bet on establi...

 cantor-fitzgerald-reiterates-overweight-on-teladoc-health-maintains-10-price-target

Cantor Fitzgerald analyst Sarah James reiterates Teladoc Health (NYSE:TDOC) with a Overweight and maintains $10 price target.

 im-not-proud-of-myself-jim-cramer-says-he-bought-worst-of-the-three-ge-stocks

Jim Cramer recommends buying Merck (MRK) due to faith in CEO Robert Davis. He advises against Teladoc (TDOC) due to Cathie Wood...

 piper-sandler-maintains-overweight-on-teladoc-health-lowers-price-target-to-10

Piper Sandler analyst Jessica Tassan maintains Teladoc Health (NYSE:TDOC) with a Overweight and lowers the price target from...

 deutsche-bank-maintains-hold-on-teladoc-health-lowers-price-target-to-10

Deutsche Bank analyst George Hill maintains Teladoc Health (NYSE:TDOC) with a Hold and lowers the price target from $15 to $10.

 truist-securities-maintains-hold-on-teladoc-health-lowers-price-target-to-10

Truist Securities analyst Jailendra Singh maintains Teladoc Health (NYSE:TDOC) with a Hold and lowers the price target from ...

 needham-reiterates-hold-on-teladoc-health

Needham analyst Ryan MacDonald reiterates Teladoc Health (NYSE:TDOC) with a Hold.

 td-cowen-maintains-hold-on-teladoc-health-lowers-price-target-to-9

TD Cowen analyst Charles Rhyee maintains Teladoc Health (NYSE:TDOC) with a Hold and lowers the price target from $15 to $9.

 whats-going-on-with-teladoc-health-stock-after-earnings

Teladoc Health shares are trading lower Thursday after the company reported a second-quarter revenue miss and withdrew its full...

 us-stocks-tumble-on-economic-geopolitical-concerns-small-caps-chipmakers-sink-meta-rallies-whats-driving-markets-thursday

Markets experienced a sharp downturn, driven by heightened geopolitical tensions and economic uncertainties that negatively imp...

 rbc-capital-maintains-outperform-on-teladoc-health-lowers-price-target-to-9

RBC Capital analyst Sean Dodge maintains Teladoc Health (NYSE: TDOC) with a Outperform and lowers the price target from $18 ...

 barclays-maintains-overweight-on-teladoc-health-lowers-price-target-to-10

Barclays analyst Steve Valiquette maintains Teladoc Health (NYSE:TDOC) with a Overweight and lowers the price target from $2...

 stifel-maintains-hold-on-teladoc-health-lowers-price-target-to-9

Stifel analyst David Grossman maintains Teladoc Health (NYSE:TDOC) with a Hold and lowers the price target from $16 to $9.

 da-davidson-maintains-neutral-on-teladoc-health-lowers-price-target-to-8

DA Davidson analyst Gil Luria maintains Teladoc Health (NYSE:TDOC) with a Neutral and lowers the price target from $12 to $8.

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION